Pfizer halts global distribution of smoking cessation pill

After finding potential carcinogens in some lots of Chantix, Pfizer (PFE) late last month halted worldwide distribution of smoking cessation pill.

The drug maker, which is now running tests, took this step after finding nitrosamine levels that were above an “acceptable” daily intake, according to the company. Consequently, regulators in Canada and South Korea, for instance, have posted recall notices for the medicine, which is called Champix outside the U.S., is recalled. Pfizer also sent letters to distributors about its actions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Source link


The leading source for trustworthy and timely health and medical news and information. Providing credible health information, supportive community, and educational services by blending award-winning expertise in content, community services, expert commentary, and medical review. Everything about health is here with the difference of Dr.About

Related Articles

Leave a Reply

Back to top button